The clinical features of a group of 30 patients with recal citrant recurrent corneal erosions (i.e. those who failed to respond to conventional therapy) were evaluated. Associ ated ocular and facial abnormalities were documented.
tear film. Dropout of meibomian glands was present in 25 (83 %) patients and was maximum in the medial half of the lid in 21 (84%) of these 25 patients. Tear film break-up time was reduced in all patients, being instant in 7 (23%), between 1 and 5 seconds in 22 (74%) and between 10 and 15 seconds in 1 (3%) patient. Superficial corneal abnormalities were present in 28 (93%) patients as manifest by maps, dots and fingerprints. Facial abnormalities such as telangiectasia, rhinophyma and acne rosacea were present in 22 (73%) patients. The find ings of our study suggest an association between recal citrant recurrent corneal erosions and meibomian gland dysfunction.
Recurrent corneal erosions were first described in 1872 by Hansen l who termed the disorder 'intermittent neuralgic vesicular keratitis'. Von Szily " in 1900 gave a compre hensive account of the disorder and illustrated the prin cipal features of the disease. Chandler 3 in 1945 , in a fascinating account of the disorder, divided the syndrome of recurrent corneal erosions into a macroform and a microform.
The macroform is characterised by widespread loss of the corneal epithelium and severe symptoms. It is well described and easily recognised by ophthalmologists. Symptoms may take several days to subside. The macro form recurs at long intervals of weeks, months or years. The microform is characterised by a small area of epi thelial loss and may easily be overlooked on clinical examination. The attacks are milder and of shorter dura tion than those of the macroform, but occur far more fre quently -sometimes every night or morning. The purpose of this study was to evaluate the clinical features and lid disease in a group of patients with recal citrant recurrent corneal erosions. We introduced the term 'recalcitrant recurrent corneal erosions' to denote those patients with recurrent corneal erosions who fail to respond to conventional therapy.
PATIENTS AND METHODS

Patient Selection
All consecutive patients with recurrent corneal erosions presenting the Birmingham and Midland Eye Hospital between April 1991 and October 1992 were considered for study entry. The criteria for inclusion were: (1) a history of recurrent corneal erosions, (2) the patient had been seen with a documented corneal epithelial loss, (3) persistent recurrent corneal erosions for 2 months, while using lubricating eye ointment every night. Patients with any corneal dystrophy other than map, dot, fingerprint dystrophy were excluded. Patients with systemic diseases known to be associated with recurrent corneal erosions, such as epidermolysis bullosa, were also excluded. All patients enrolled in this study were entered in a treatment trial for recurrent corneal erosions and are the subject of a subsequent report. 6 At the initial study visit, details of age, sex, any history of trauma and previous ocular and medical diseases were recorded. The duration and nature of symptoms, and the frequency and type of recurrent corneal erosions were documented.
A complete ophthalmological examination was carried out, including best corrected visual acuity and indirect ophthalmoscopy. Slit lamp biomicroscopy was performed and the tear film assessed for the presence of debris. The cornea was examined using retroillumination to assess the presence of subtle abnormalities such as cysts, maps, dots and fingerprints. The site of corneal epithelial abnormal-ities was assessed and recorded by a specially prepared scale placed over the proforma, dividing the cornea into thirds: inferior, middle and superior.
The meibomian glands were assessed with the tech nique of lid transillumination, using a scleral transillum inator.. The number of meibomian glands was counted in each lower lid. Meibomian gland dropout was defined as mild, moderate or severe. The lid was divided into a medial and a lateral half. A count of between 10 and 12 meibomian glands per half-section was defined as mild dropout of the meibomian glands, between 5 and 10 mei born ian glands per half-section was defined as moderate dropout and a count below 5 in each section was defined as severe dropout. The meibomian glands were assessed for the presence or absence of inspissation at the lid orifices.
Tear film break-up time (TBUT) was measured using one drop of preservative-free 2% sodium fluorescein prior to instillation of any other medication. A drop of fluor escein was instilled, and the interval between the last com plete blink and the development of the first randomly distributed dry spot in the precorneal tear film measured using a stop-watch. Non-randomly distributed dry spots overlying localised areas of elevated epithelium were ignored when measuring the TBUT. The lids were not held for this procedure. TBUT was measured for both eyes and the two results averaged. The results of the TBUT were divided into five groups: instant, between I and 5 seconds, between 5 and 10 seconds, between 10 and 15 seconds and over 15 seconds. A TBUT of over 15 seconds was defined as normal.
The Schirmer test was performed, without the use of local anaesthetic. Aqueous production was measured 5 minutes following insertion of the filter paper and the result expressed in millimetres. A result of over 5 mm was defined as normal.
The facial features were examined and particular note taken of facial telangiectasia, rhinophymna, pustules and papules.
RESULTS
The results of this study are shown in Tables I-VII. The age and sex distribution of the patients is shown in Table 1 . The type of erosion and the incidence of bilateral disease is shown in Ta ble II. The nature of the initial pre cipitating injury is shown in Table Ill . A fingernail injury was the commonest form of injury identified. One patient underwent general anaesthesia for a minor procedure and subsequent to this developed a painful eye and developed recurrent corneal erosions. Two patients suffered from diabetes and I from rheumatoid arthritis. A positive family history of recurrent corneal erosions was identified in 2 patients: one 49-year-old woman had a daughter with recurrent corneal erosions and one 31-year-old man had an affected father.
All patients complained of pain associated with the development of a recurrent corneal erosion. In addition, 22 (74%) of 30 patients suffered from pain, photophobia and lacrimation, 4 (13%) from pain and photophobia, 3 (10%) M. W. HOPE-ROSS ET AL. experienced pain and lacrimation and I (3%) patient experienced pain only. Symptoms occurred either during the night or on wak ing. On waking, 17 (56%) of 30 patients suffered a sharp pain accompanied by lacrimation. Five patients (17%) suffered symptoms only at night and were woken from their sleep with pain. Eight patients (27%) had a combi nation of the above and had symptoms during the night and also on waking. Specific factors which could pre cipitate and aggravate recurrent corneal erosions were identified in half the patients (Table IV) . Of the 17 women in the study, 7 (41 %) identified hormonal events such as menstruation, pregnancy and menopause as aggravating factors which precipitated an increased number of recur rent corneal erosions.
Ocular examination revealed meibomian gland dys function in all 30 patients (Table V) . Microscopic tear film debris was present in all patients (Fig. I) . Tear film break-up time was reduced in all patients, being instant in 7 (23%), between 1 and 5 seconds in 22 (74%) and between 10 and IS seconds in I (3%) patient.
The number of meibomian glands was reduced in 25 (83%) of the 30 patients (Fig. 2) . Meibomian gland drop- out was severe in 3 (12%) patients, moderate in 8 (32%) and mild in 14 (56%) patients. Meibomian gland dropout was located medially in 21 (84%) patients, laterally in I (4%), and in 3 (12%) patients the entire lid was affected (Fig. 2) . The orifices of the meibomian glands were inspissated in 2 5 (83%) of 30 patients (Fig. I) . Lid scales and collarettes around the hair follicles were present in 6 patients. Bilateral superficial corneal vas cularisation, located superiorly was present in 3 patients. The aqueous component of the tear film, as assessed by the Schirmer test, was normal in 29 patients. The aqueous component of the tear film was abnormal in 1 patient and the Schirmer test was 4 mm in the right eye and 6 mm in the left.
Corneal examination revealed microcysts, fingerprints and maps in 28 (93%) of 30 patients (Table VI, Fig. 3 ). All 9 patients with bilateral recurrent corneal erosions demon strated corneal abnormalities in both eyes. In unilateral cases of recurrent corneal erosions, no corneal abnormal ity was present in 2 (5%) patients. Corneal cysts, seen in 21 (54%) of 39 eyes, were the commonest corneal abnormality, and cysts were also seen in combination with maps and fingerprints in 14 (36%) eyes. Fingerprints only were present in 2 (5%) eyes.
In the 21 patients with unilateral recurrent corneal ero sions, 7 (33%) patients had corneal abnormalities in the fellow eye. Examination of the fellow eye in these patients demonstrated fingerprints in 4 (57%) of 7 eyes, microcysts in 2 (29%) eyes and microcysts and fingerprints in I (14%) eye.
The distribution of the corneal abnormalities was noted to be predominantly in the inferior third of the cornea, and although superior involvement did occur, this was always in the presence of inferior corneal involvement (Fig. 4) . Fifteen (4 1%) of 37 affected eyes demonstrated corneal abnormalities in the inferior third of the cornea, in 14 (38%) the inferior and middle third of the cornea was involved, in 5 (13%) the involvement was limited to the middle third of the cornea, and in 3 (8%) eyes there was involvement of the entire cornea.
Twenty-two (73%) of 30 patients demonstrated facial abnormalities seen in acne rosacea. Cutaneous telangiec tasia, rhinophyma, pustules and papules were noted (Table VII) . Eight (27%) patients had no facial abnormality.
DISCUSSION
Recurrent corneal erosions occur spontaneously, follow ing trauma, or in association with corneal dystrophies and secondary to certain systemic diseases. � Epithelial, stromal and endothelial corneal dystrophies have all been described in association with recurrent cor neal erosions. " These inherited recurrent corneal erosions may be subclassified into two main groupS. 4 Epithelial corneal dystrophies associated with recurrent corneal ero sions include Francheschetti type, epithelial rosette dys trophy, map, dot, fingerprint dystrophy (epithelial basement membrane dystrophy) and Meesman's dys trophy. Other corneal dystrophies associated with recur rent corneal erosions include Reiss-Buckler's dystrophy and the stromal dystrophies, macular, granular and less commonly lattice dystrophy. Endothelial dystrophies may be complicated by recurrent corneal erosions in the later stages when there is corneal decompensation and oedema.
The pathogenesis of recurrent corneal erosions associ ated with inherited corneal dystrophies and systemic dis eases such as epidermolysis bullosa differs from that associated with spontaneous or traumatic recurrent cor-
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neal erosions. 7 , x These diseases were excluded from our study. In our opinion, recurrent corneal erosions occurring in map, dot, fingerprint dystrophy may have a similar pathogenesis to the spontaneous or traumatic form and these patients were therefore included in the study.
Map, dot, fingerprint dystrophy, also known as base ment membrane epithelial dystrophy, was initially reported by Cogan, 9 who described repeated attacks of spontaneous recurrent corneal erosions associated with a variety of superficial corneal changes. The corneal changes included epithelial microcysts, bleb patterns, nets, fingerprints, lines and maps. Brown and Bron lo further defined the nature of superficial lines, describing mare's-tail lines, fibrillary lines and tram lines.
Laibson and Krachm d I identified 20 kinships with the map, dot, fingerprint dystrophy. A dominant mode of inheritance was proposed but this failed to explain the pre dominance of women affected with the disorder. Others have questioned this mode of inheritance; Werblin et al. 12 felt that the family association was spurious. There is still debate about the inheritance of map, dot, fingerprint dystrophy. "
Traumatic recurrent corneal erosions are known to be associated with epithelial microcysts. The differentiation between the traumatic form of recurrent corneal erosions and that associated with map, dot, fingerprint dystrophy is made on the finding of fingerprints, nets and blebs in the latter condition. 13 The association of recalcitrant recurrent corneal ero sions and meibomian gland dysfunction has not pre viously been noted. We evaluated ocular and facial abnormalities in a group of patients with recalcitrant recurrent corneal erosions and found that all patients with recalcitrant recurrent corneal erosions had meibomian gland dysfunction.
Meibomian gland dysfunction was manifest by dropout and inspissation of the meibomian glands, debris in the tear film, and reduced tear film break-up time. Dropout of the meibomian glands was present in 25 (83%) of 30 patients. Tear film break-up time was reduced in all patients. Meibomian gland dysfunction is associated with acne rosacea; we demonstrated facial abnormalities seen in association with acne rosacea in 22 (73%) of 30 patients.
We found the corneal abnormalities present in recal citrant recurrent corneal erosions to be located principally in the inferior and middle thirds of the cornea. Other inves tigators have also documented this finding. s No explana tion has been advanced, however, to explain this finding.
Seven (4 1 %) of the 17 women in the study identified hormonal factors such as menstruation, pregnancy and the menopause as causing a worsening of the recurrent cor neal erosions. The relationship of recurrent corneal ero sions to menstruation has been noted previously but has remained unexplained. 13 The stimulus for secretion of lipid by the meibomian glands is not fully known. It is assumed that the secretion of meibomian glands is modu lated by the levels of plasma sex hormones, as the meibo-mian glands are sebaceous glands and the role of sex hormones in the modulation of sebaceous secretion is well known. 14 Meibomian gland dysfunction is, we believe, impli cated in the pathogenesis of recalcitrant recurrent corneal erosions. The evidence for this view is as follows:
1. Meibomian gland dysfunction was present in a group of patients with recalcitrant recurrent corneal erosions. 2. Patients with recalcitrant recurrent corneal erosions respond to treatment of the associated of the meibo mian gland dysfunction. 6 3. Corneal abnormalities associated with recurrent cor neal erosions are located in the inferior and middle third of the cornea, that part of the cornea that has maximum contact with the tear film. 4. Women identify hormonal changes as increasing the frequency of recurrent corneal erosions. Meibomian glands are believed to be modulated by sex hormones.
The exact mechanism by which meibomian gland dys function may be implicated in the pathogenesis of the disease is unknown. It is possible that pre-existing map. dot, fingerprint dystrophy and associated recurrent corneal erosions may be aggravated by accompanying meibomian gland dysfunction. Alternatively, meibomian gland dys function may predispose susceptible individuals to the development of recurrent corneal erosions either sponta neously or in response to trauma. This previously unrecognised association of meibo mian gland dysfunction and recurrent corneal erosions lends a whole new perspective to the role of the tear film in the pathogenesis of superficial corneal disorders. It has allowed us to treat recalcitrant recurrent corneal erosions successfully. 6 Further research into this aspect of the dis order may lead to clarification of the pathogenesis of recurrent corneal erosions and superficial corneal disorders.
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